Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Neoplasms × Patient Navigation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 3 Lung Neoplasms 2 Uterine Cervical Neoplasms 1 Tobacco Use 1 Smoking 1 Patient Compliance 1 Papillomavirus Infections 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma 1 Head and Neck Neoplasms 1

Interventions

Gemcitabine 43 Paclitaxel 41 Carboplatin 37 pembrolizumab 36 Cyclophosphamide 36 Bevacizumab 34 Fluorouracil 26 Docetaxel 26 Cisplatin 26 Nivolumab 23 Capecitabine 23 Pemetrexed 21 Oxaliplatin 19 Leucovorin 19 Irinotecan 19 Dexamethasone 19 Sorafenib 18 Ipilimumab 17 Everolimus 17 Radiotherapy 15 Erlotinib Hydrochloride 15 Doxorubicin 15 Cetuximab 14 fludarabine 13 Rituximab 13 Lapatinib 13 eribulin 12 Sunitinib 12 Prednisone 12 Fulvestrant 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03821064 2021-02-01

NDURE

Medical University of South Carolina

Phase NA Completed

11 enrolled 28 charts

Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡